SALIX PHARMACEUTICALS LTD Net Cash Provided by (Used in) Financing Activities, Continuing Operations
SALIX PHARMACEUTICALS LTD reported Net Cash Provided by (Used in) Financing Activities, Continuing Operations of $1.85 billion for the 9-month period ending 2014-09-30, per its 10-Q/A filed 2015-03-02.
Discontinued › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations · last filed 2015-03-02
- SALIX PHARMACEUTICALS LTD net cash provided by (used in) financing activities, continuing operations for the quarter ending 2014-09-30 was -$19.31M.
- SALIX PHARMACEUTICALS LTD net cash provided by (used in) financing activities, continuing operations for the quarter ending 2014-06-30 was -$3.46M, a 179.60% decline year-over-year.
- SALIX PHARMACEUTICALS LTD net cash provided by (used in) financing activities, continuing operations for the quarter ending 2014-03-31 was $1.88B.
- SALIX PHARMACEUTICALS LTD net cash provided by (used in) financing activities, continuing operations for the quarter ending 2013-09-30 was -$8.77M.
| Period end | Net Cash Provided by (Used in) Financing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Financing Activities, Continuing Operations 3 month as first filed | Net Cash Provided by (Used in) Financing Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Financing Activities, Continuing Operations 6 month as first filed | Net Cash Provided by (Used in) Financing Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Financing Activities, Continuing Operations 9 month as first filed |
|---|---|---|---|---|---|---|
| 2014-09-30 | -$19.31M derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2015-03-02 | -$22.77M derived: sum of 2 quarters · filed 2015-03-02 | $1.85B 10-Q/A · filed 2015-03-02 | $1.85B 10-Q · filed 2014-11-07 | ||
| 2014-06-30 | -$3.46M derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2015-03-02 | $1.87B 10-Q/A · filed 2015-03-02 | $1.87B 10-Q · filed 2014-08-08 | |||
| 2014-03-31 | $1.88B 10-Q/A · filed 2015-03-02 | $1.88B 10-Q · filed 2014-05-09 | ||||
| 2013-09-30 | -$8.77M derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2015-03-02 | -$4.42M derived: sum of 2 quarters · filed 2015-03-02 | -$4.78M 10-Q/A · filed 2015-03-02 | |||
| 2013-06-30 | $4.35M derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2015-03-02 | $3.99M 10-Q/A · filed 2015-03-02 | ||||
| 2013-03-31 | -$360.00K 10-Q/A · filed 2015-03-02 |